Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review
Value in Health · 2024-01 · 27 (1) · 117-128
DOI: 10.1016/j.jval.2023.08.003 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Value in Health, 2024-01. Verfasst von M Rifqi Rokhman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Global Health, Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Insti…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Mass Screening. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rijksuniversiteit Groningen.
Abstract (Originalsprache)
OBJECTIVES: The aim of this review is to appraise and assimilate evidence from studies that have reported on the cost-effectiveness of screening programs for chronic kidney disease (CKD). METHODS: The study protocol was registered on International Prospective Register of Systematic Reviews (PROSPERO). The final search was conducted on 18 January 2023 using 7 databases. Screening of articles, data extraction, and quality assessment was performed by 2 independent reviewers. The ISPOR-AMCP-NPC checklist was used to assess the credibility of the included studies. RESULTS: From 4948 retrieved studies, a final total of 20 studies were included in the qualitative synthesis. Studies found that screening in diabetic populations was cost-effective (n = 8, 57%) or even cost-saving (n = 6, 43%). Four studies (67%) found that screening in hypertensive populations was also cost-effective. For the general population, findings were inconsistent across studies in which many found screening to be cost-effective (n = 11, 69%), some cost-saving (n = 2, 12%), and others not cost-effective (n = 3, 19%). The most influential parameters identified were prevalence of CKD and cost of screening. CONCLUSIONS: Screening for CKD in patients with diabetes or hypertension is recommended from a cost-effectiveness point of view. For the general population, despite some inconsistent findings, the majority of studies demonstrated that screening in this population is cost-effective, depending mainly on the prevalence and the costs of screening. Healthcare decision makers need to consider the prevalence, stratification strategies, and advocate for lower screening costs to reduce the burden on healthcare budgets and to make screening even more favorable from the health-economic perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Global Health, Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Institute of Science in Healthy Ageing & healthcaRE (SHARE), University Med…
- Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Division of Pharmacology and Therapy, Department of Anatomy, Histology,…
- Unit of Global Health, Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
- Unit of Global Health, Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Faculty of Management Sciences, Open University, Heerlen, The Netherlands.
Förderung
- Rijksuniversiteit Groningen
Zitieren
APA
Rokhman, M. R., Alkaff, F. F., van Dorst, P. W. M., At Thobari, J., Postma, M. J., van der Schans, J., & Boersma, C. (2024). Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review. Value in Health, 27(1), 117-128. https://doi.org/10.1016/j.jval.2023.08.003
Vancouver
Rokhman MR, Alkaff FF, van Dorst PWM, At Thobari J, Postma MJ, van der Schans J, et al. Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review. Value in Health. 2024;27(1):117-128. doi:10.1016/j.jval.2023.08.003
BibTeX
@article{Rokhman2024,
author = {Rokhman, M Rifqi and Alkaff, Firas Farisi and van Dorst, Pim W M and At Thobari, Jarir and Postma, Maarten J and van der Schans, Jurjen and Boersma, Cornelis},
title = {Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review},
journal = {Value in Health},
year = {2024},
volume = {27},
number = {1},
pages = {117--128},
doi = {10.1016/j.jval.2023.08.003}
}
EUVIMED